The FORE-SIGHT Absolute Cerebral Oximeter has been expanded to include children over 40kg and infants.
The initial market focus is on high-risk cardiovascular surgeries, of which there are about 700,000 performed each year in the U.S. Additional market opportunities include a broad range of general surgical procedures and postoperative and critical care settings.
The FORE-SIGHT Cerebral Oximeter provides new information that allows clinicians to monitor and respond to instances of brain tissue oxygen deprivation before damage to the brain occurs.